2021 Access to Medicine Index: No profit, no pharma?

Writing for Deutsche Welle, Zulfikar Abbany dives into the 2021 Access to Medicine Index and focuses on the slow progress of the pharmaceutical industry in improving access to medicines and vaccines, citing profitability as the main driver behind the companies' actions.

Zulfikar presents the ranking of the top 10 companies and reports on the diseases targeted more extensively by the pharmaceutical companies, making particular reference to the diseases which are usually overlooked.

The articles also underlines the role of COVID-19 in mobilising the companies and quotes Jayasree K. Iyer on the pathogen that could cause the next pandemic and the companies' role in getting prepared.

Read the full article here.